Home›Companies›Biotech & Pharma›LeanBio Therapeutics

LeanBio Therapeutics, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 7, 2026·Latest SEC filing Oct 22, 2026·Suggest an edit

About LeanBio Therapeutics

LeanBio Therapeutics is a private company based in Brookline, Massachusetts, incorporated in 2026 in Delaware. It has reported $0 raised in one offering on Form D since October 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetOct 22, 2026$0target not set0—Equity, Options, Securities on exerciseRule 506(b), 4a5Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on LeanBio Therapeutics's Form D filed Oct 22, 2026.

MP
Michal Preminger
Executive officer and director
WH
William Hait
Executive officer and director

Sources

  1. SECLeanBio Therapeutics, Inc. filing history